Shareholders meeting

Ref: Syn/CS/SE/AGM/2026-27/Jul/02 Syngene International Limited Biocon SEZ, Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area, IV Phase, Jigani Link Road, Bengaluru 560099, Karnataka, India. T +91 80 6891 9191 CIN: L85110KA1993PLC014937 www.syngeneintl.com July 02, 2026 To, To, The Manager, The Manager, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Corporate Communication Department Dalal Street, Mumbai – 400 001 Bandra (EAST), Mumbai – 400 051 Scrip Code: 539268 Scrip Symbol: SYNGENE Dear Sir/Madam, Subject: Notice of 33rd Annual General Meeting (“AGM”) We wish to inform you that the 33rd AGM of the Company will be held on Wednesday, July 29, 2026 at 3:30 pm (IST) through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”). In this regard, please find enclosed the Notice of the 33rd AGM of the Company, which is being circulated to the shareholders through electronic mode. The Notice is also available on the Company’s website at https://www.syngeneintl.com/investors/share-holder-services/ Request you to kindly take this intimation on record. Thanking You, Yours faithfully, For SYNGENE INTERNATIONAL LIMITED Chethan Yogesh Company Secretary & Compliance Officer Enclosed: Notice of the 33rd AGM Notice Notice is hereby given that the 33rd Annual General Meeting ITEM NO. 3: TO CONSIDER AND APPROVE THE (“AGM”) of Syngene International Limited will be held on APPOINTMENT OF PROFESSOR CATHERINE ROSENBERG Wednesday, July 29, 2026, at 3:30 PM IST through Video (DIN: 06422834) AS DIRECTOR LIABLE TO RETIRE BY Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”) ROTATION to transact the following business: To appoint a director in place of Professor Catherine Rosenberg ORDINARY BUSINESS: (DIN: 06422834), Non-Executive Director, who retires by rotation and being eligible, offers herself for re-appointment. ITEM NO. 1: ADOPTION OF AUDITED FINANCIAL STATEMENTS To consider and if thought fit, to pass the following resolution as an Ordinary Resolution: To receive, consider and adopt the standalone and consolidated financial statements of the Company for the financial year “RESOLVED THAT pursuant to the provisions of Section 152 ended March 31, 2026 and other applicable provisions of the Companies Act, 2013, if any, Professor Catherine Rosenberg (DIN: 06422834), who To consider and if thought fit, to pass the following resolution retires by rotation at this Meeting and being eligible has offered as an Ordinary Resolution: herself for re-appointment, be and is hereby re-appointed as Director of the Company, liable to retire by rotation.” “RESOLVED THAT pursuant to Section 137 of the Companies Act, 2013 and Regulation 33 and 41 of the SEBI Listing ITEM NO. 4 Regulations, 2015 the audited standalone financial statements of the Company including the Balance Sheet as at March APPOINTMENT OF M/S S. R. BATLIBOI & ASSOCIATES 31, 2026, profit and loss account, the cash flow statement LLP, CHARTERED ACCOUNTANTS AS THE STATUTORY for the year ended on that date, report of Board of Directors AUDITORS OF THE COMPANY and auditors thereon and the audited consolidated financial statements of the Company including auditor’s report thereon To consider and, if thought fit, to pass the following resolution be and are hereby received, considered and adopted.” as an Ordinary Resolution ITEM NO. 2: DECLARATION OF DIVIDEND “RESOLVED THAT pursuant to the provisions of Sections 139, 142 and other applicable provisions, if any, of the Companies To declare a final dividend of `1.25 per equity share for the Act, 2013 read with the rules made thereunder, as amended Financial Year ended March 31, 2026. from time to time (including any statutory modification(s), amendment(s) or re-enactment(s) thereof for the time being To consider and if thought fit, to pass the following resolution in force), and based on the recommendation of the Audit as an Ordinary Resolution: Committee and the Board of Directors, S. R. Batliboi & Associates LLP, Chartered Accountants (ICAI Firm Registration “RESOLVED THAT pursuant to Section 123 of the Companies No. 101049W/E300004) be and are hereby appointed as Act, 2013, read with relevant rules, if any framed thereunder, the Statutory Auditors of the Company, to hold office for a a final dividend at the rate of `1.25 per equity share having a face value of ` 10 each, as recommended by the Board of term of five consecutive years from the conclusion of the 33rd Annual General Meeting until the conclusion of the 38th Annual Directors, be and is hereby declared for the financial year ended General Meeting of the Company, on such remuneration and March 31, 2026, and that the same be paid to those members reimbursement of out-of-pocket expenses as may be mutually whose names appear in the Company’s Register of Members agreed upon between the Board of Directors and the Statutory and in the Register of Beneficial Owners maintained by the Auditors; Depositories as on the record date.” 376 | Syngene International Limited Business Review Statutory Reports Financial Statements RESOLVED FURTHER THAT the Board of Directors of the subject to the provisions of the Act, Schedule V thereto and the Company or any duly constituted Committee thereof be and SEBI Listing Regulations. is hereby authorised to do all such acts, deeds, matters and things, execute all such documents, forms and writings, and RESOLVED FURTHER THAT in the event of absence or take all such steps as may be deemed necessary, proper or inadequacy of profits in any financial year during the aforesaid expedient in connection with or incidental to giving effect to period, the remuneration payable to the directors of the the foregoing resolution.” Company shall be governed by the limits prescribed under Section II of Part II of Schedule V to the Act or such other SPECIAL BUSINESS: limits as may be approved by the Members or prescribed by the Central Government or any other statutory authority from ITEM NO. 5 time to time. TO APPROVE THE PAYMENT OF REMUNERATION TO RESOLVED FURTHER THAT the Board of Directors of the DIRECTORS IN CASE OF ABSENCE / INADEQUATE PROFITS Company (including the Nomination and Remuneration IN EXCESS OF THE LIMITS PRESCRIBED UNDER THE Committee or any other Committee authorised by the Board for COMPANIES ACT, 2013 this purpose) be and is hereby authorised to alter, vary, enhance or revise the remuneration payable to the directors within the To consider and, if thought fit, to pass the following resolution aforesaid limits and in accordance with the provisions of the as a Special Resolution: Act, Schedule V and applicable SEBI Listing Regulations. “RESOLVED THAT pursuant to the provisions of Sections 196, RESOLVED FURTHER THAT the Board of Directors, Key 197, 198, Schedule V and all other applicable provisions, if any, Managerial Personnel and/or Company Secretary of the of the Companies Act, 2013 (“Act”) read with the Companies Company be and are hereby severally authorised to do all (Appointment and Remuneration of Managerial Personnel) such acts, deeds, matters and things and to execute all such Rules, 2014, Regulation 17(6)(e) and other applicable documents, filings and writings as may be necessary, expedient provisions, if any, of the Securities and Exchange Board of India or desirable in connection with and incidental to giving effect (Listing Obligations and Disclosure Requirements) Regulations, to this Resolution.” 2015 (“SEBI Listing Regulations”), the Articles of Association of the Company and subject to such other approvals, permissions ITEM NO. 6: and sanctions as may be necessary, approval of the Members of the Company be and is hereby accorded for payment TO APPROVE THE APPOINTMENT OF MR. SIDDHARTH of remuneration to the Executive Directors, Non-Executive MITTAL (DIN: 03230757) AS THE MANAGING DIRECTOR Directors and/or Independent Directors of the Company, for a AND CHIEF EXECUTIVE OFFICER OF THE COMPANY AND period of three financ [Showing first 8,000 characters — download PDF for full document]